07.10.2013 • NewsK+SPotashpotash business

K+S Potash Mine Could Close for Weeks after Deadly Blast

The German potash mine operated by K+S where three workers died from carbon dioxide poisoning may have to close for weeks, the fertiliser company's chief executive said.

The deadly blast happened on Tuesday Oct. 1 after a controlled explosion at the mine in the German state of Thueringia caused a blowout of CO2, which occurs naturally in the salt rock.

It may take "from days to a few weeks" to fan the gas out of the mine and for mining authorities and public prosecutors to complete their investigations, Chief Executive Norbert Steiner told Reuters.

The mine accounts for almost 1 million tonnes of the group's annual output in potash products of 7 million, according to the company. The accident occurred in a 700-metre-deep shaft near the town of Unterbreizbach. Four other miners were rescued.

Carbon dioxide occurs in pressurised liquid form in potash deposits that are mined using controlled explosions and when it vaporises, it expands 100 times in volume. The gas flooded the entire mine within seconds of the blast, causing a plume of salty dust to shoot up the mineshaft about 11 km (7 miles) from the site of the blowout.

 

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.